(600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Operating Data for the First Three Quarters of 2026
Filed with SSE · Stock code 600267 · · 2 pages · Chinese
Summary by 6ix AI
Zhejiang Hisun Pharmaceutical Co., Ltd. has announced its operating data for the first three quarters of the year.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by Subsidiary
- Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by a Subsidiary
Earlier from Zhejiang Hisun Pharmaceutical
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
- (600267)"Zhejiang Hisun Pharmaceutical Co., Ltd."Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by Subsidiary
- Indicative Announcement on Results of the Agreement-based Transfer of the Company's Shares by Shareholder Holding More Than 5% of the Shares through Public Solicitation and Signing of the Share Transfer Agreement with the Transferee
- Announcement on Obtaining the Approval for Veterinary Drug Product Approval Number by a Subsidiary
- Announcement on the Company's Product Passing the U.S. Self-GRAS Certification
Later from Zhejiang Hisun Pharmaceutical
All Zhejiang Hisun Pharmaceutical news releasesFollow Zhejiang Hisun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Hisun Pharmaceutical